Clinical Trial

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

Withdrawn Phase 3
View on ClinicalTrials.gov →
Summary
This study is being done to find out how well a medicine called CagriSema helps people with overweight or obesity lose weight. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance using a computer program, so neither participants nor study staff will know which treatment is given. The study will last for about one year.
Protocol Amendment History 3 changes
critical Trial status changed: NOT_YET_RECRUITING → WITHDRAWN 2026-07-10
critical Reason stopped changed: — → The study is withdrawn due to strategic reasons. 2026-07-10
notable Enrollment reduced: 1400 -> 0 participants 2026-07-10
Trial Details
NCT Number NCT07357766
Lead Sponsor Novo Nordisk A/S
Conditions Overweight, Obesity
Start Date 2026-06-22
Primary Completion 2027-11-29 (estimated)
Study Completion 2028-01-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-09